Identification of predictive factors for post-transarterial chemoembolization liver failure in hepatocellular carcinoma patients: A retrospective study

Figure 1 Nomogram for probability of post-transarterial chemoembolization liver failure in hepatocellular carcinoma patients. A: The nomogram model; B: The calibration curve of the nomogram model with internal validation through bootstrapping. TACE: Transarterial chemoembolization.

Figure 2 Receiver operating characteristic curves of predictors for post-transarterial chemoembolization liver failure. A: Receiver operating characteristic (ROC) of microspheres plus gelatin embolization; B: ROC of main tumor size > 5 cm; C: ROC of resection history; D: ROC of the nomogram model. AUC: Area under the curve; CI: Confidence interval.

Figure 3 Frequency of post-transarterial chemoembolization liver failure. A: Occurrence of post-transarterial chemoembolization (TACE) liver failure by microspheres plus gelatin embolization; B: Occurrence of post-TACE liver failure by main tumor size; C: Occurrence of post-TACE liver failure by resection history. TACE: Transarterial chemoembolization.